Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
DBTX | Decibel Therapeutics | 10.83 | 0.42 | 4.03% |
You can purchase shares of Decibel Therapeutics (NASDAQ: DBTX) through any online brokerage.
Other companies in Decibel Therapeutics’s space includes: Neurocrine Biosciences (NASDAQ:NBIX), CureVac (NASDAQ:CVAC) and Amgen (NASDAQ:AMGN).
The latest price target for Decibel Therapeutics (NASDAQ: DBTX) was reported by Citigroup on 2021-03-09. The analyst firm set a price target for 29.00 expecting DBTX to rise to within 12 months (a possible 167.77% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Decibel Therapeutics (NASDAQ: DBTX) is $10.83 last updated Wed Apr 14 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Decibel Therapeutics.
There is no upcoming split for Decibel Therapeutics.